These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7016930)

  • 1. Lofexidine in the treatment of hypertension: a twice-daily versus one-daily dose comparison with 24-hour blood pressure monitoring.
    Garrett BN; Kaplan NM
    J Clin Pharmacol; 1981 Apr; 21(4):173-80. PubMed ID: 7016930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lofexidine and clonidine in moderate essential hypertension.
    Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
    Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
    Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
    J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.
    Miyoshi K; Okura T; Nagao T; Masanori J; Irita J; Higaki J
    Clin Ther; 2013 Sep; 35(9):1418-22. PubMed ID: 23972579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effect of lofexidine with a diuretic in hypertension.
    Vlachakis ND; Velasquez M; Alexander N; Maronde RF
    Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
    McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
    Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of lofexidine in patients with essential hypertension.
    Fagan TC; Bloomfield SS; Cowart TD; Corns-Hurwitz RH; Lipicky RJ; Conradi EC; Hsu CY; Grossman WJ; Harmon GE; Degenhart WJ; Sinkfield AW; Gaffney TE
    Br J Clin Pharmacol; 1982 Mar; 13(3):405-10. PubMed ID: 7059442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
    Lopez LM; Mehta JL
    Am J Cardiol; 1984 Mar; 53(6):787-90. PubMed ID: 6702628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enalapril in low-renin essential hypertension.
    Wilkins LH; Dustan HP; Walker JF; Oparil S
    Clin Pharmacol Ther; 1983 Sep; 34(3):297-302. PubMed ID: 6309461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T; Himmelmann A
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
    Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
    JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine.
    Fyhrquist F; Kurppa K; Huuskonen M
    Acta Med Scand; 1975 Jun; 197(6):457-61. PubMed ID: 1155220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine-chlorthalidone combination once and twice daily in essential hypertension.
    Noveck RJ; McMahon FG; Jain AK; Ryan JR
    Clin Pharmacol Ther; 1980 Nov; 28(5):581-6. PubMed ID: 7438676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.